Presentation Details:
This talk addresses the following topics:
Update on 2-drug (dual) ART
TANGO (DTG/3TC as maintenance ART)
DUALIS (Boosted DRV + DTG as maintenance ART)
GEMINI (DTG/3TC as initial ART)
New antiretroviral agents
Fostemsavir (FTR)
Islatravir (ISL)
Presentation Transcript: